INCB054828
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for INCB054828, covering 2024-05-08 to 2024-05-08. Get the full timeline:
Most recent: Clinical Trial Update: Fibroblast Growth Factor (FGFs) / Fibroblast Growth Factor Receptor (FGFRs) Genetic as a Second-line Therapy for Recurrent / Progressive Gastric Cancer With INCB054828 and Paclitaxel a Study to Evaluate the Safety and Efficacy of Combination Therapy. [Phase 1, Phase 2]